Biotecnología
Biotecnología
Hovione, Laxxon Medical Partner on 3D Screen Printed Pharmaceutical Apps
23/03/2023 -
The alliance will create an opportunity for the pharmaceutical industry to develop and manufacture clinical materials and secure industrial scale production under cGMP.
Stäubli Robotics to Showcase Next Gen Pharma Robots at Interphex 2023
23/03/2023 -
Robots help manufacturers meet regulatory requirements and scale production while keeping product safety and efficacy front and center.
Remedium, Exothera Partner on Scale-Up, Demonstration Runs for AAV2-FGF18
23/03/2023 -
Exothera will focus on identifying a high yield production process and reduce cost of goods for the manufacturing process of Remedium’s AAV2-FGF18.
Syneos Health, KX Partner on Data Insights and AI Solutions
23/03/2023 -
Aims to deliver data-driven predictive analytics, Artificial Intelligence and Machine Learning capabilities for complex clinical development.
Arzeda, Takeda Partner to Accelerate Protein Biologics Optimization
23/03/2023 -
Aims to deploy AI-based protein design to optimize the properties of protein biologics in Takeda's research pipeline.
Infinity Laboratories Names Hank Nowak Commercial Ops SVP
23/03/2023 -
Nowak will lead the sales and markeing strategy.
TC BioPharm Restructures, Cuts Workforce up to 30%
23/03/2023 -
Actions are expected to result in cost savings of $3 million on an annual basis to prioritize its pending lead U.S. clinical programs.
NImmune Biopharma Launches with Phase 3-Ready Clinical Candidate Omilancor
23/03/2023 -
The once-daily, oral, gut-restricted therapeutic for Ulcerative Colitis has potentially fast-to-market follow-on opportunities in Crohn’s disease and psoriasis.
Biohaven Licenses Oral, Brain-Penetrant for Immune-Mediated Brain Disorders
23/03/2023 -
Anticipates initiating Phase 1 clinical development in 2023.
Woodstock Sterile Solutions Completes Analytical Lab Expansion
23/03/2023 -
Doubles the size of the company’s lab, expanding analytical expertise and capabilities.
Enveric Biosciences Creates Australia-based Subsidiary to Accelerate Lead Program
23/03/2023 -
Clinical trial investigating Enveric’s lead product candidate, EB-373 targeting anxiety disorder expected to initiate in the fourth quarter of 2023.
Synthego Unveils CRISPR Discovery Partners to Streamline Drug Research
22/03/2023 -
Partnership network combines the power of automated CRISPR cell line engineering with phenotypic, functional and multi-omic assays to optimize research work.
KBI Biopharma Releases Inaugural FIH Manufacturing Batch at Geneva Facility
22/03/2023 -
Milestone affirms KBI and Selexis SA’s Geneva cGMP site is operational and running successfully.
Samsung Biologics Expands Capacity with Fifth Plant
22/03/2023 -
Plant 5 will have 180,000 liters of manufacturing capacity, expanding the company's total site capacity to 784,000 liters upon completion.
Adare Pharma Solutions Chooses Vantage to Lead Packaging Facility Upgrade
22/03/2023 -
The site provides a full range of solid-dose contract packaging services at both clinical and commercial scale.
BioNTech, OncoC4 Partner to Develop mAb Candidate ONC-392 in Cancer
22/03/2023 -
OncoC4 will receive a $200 million upfront and is eligible to receive development, regulatory and commercial milestone payments as well as royalties.
FLAMMA to Invest $200M Over the Next Three Years
22/03/2023 -
Projects include upgrades to existing analytical services, the installation of new equipment, including reactors, filter dryers, and distillation units.
Pii Forms New Leadership Team
22/03/2023 -
Experts have been appointed to key management roles to instill a culture of excellence and dedication to customer service.
Syneos Health Partners with Microsoft to Optimize Clinical Trials
22/03/2023 -
Aims to deliver technology and data solutions to help fast-track timelines, optimize resource allocation, and create clinical trial efficiencies.
Hovione, Ripple Enter Strategic Drug Delivery Pact
22/03/2023 -
Partnership aims to expand the use of Ripple's Epidel platform beyond ophthalmic applications.
Lifecore Biomedical Signs Term Sheet to Expand CDMO Relationship
22/03/2023 -
Provides $10 million upfront cash commitment to Lifecore for infrastructure preparation and production capacity preparation.
